<DOC>
	<DOCNO>NCT02043730</DOCNO>
	<brief_summary>Pancreatic cancer fourth cause cancer mortality : different treatment approach locally advance pancreatic cancer management . Generally , gemcitabine alone consider reasonable approach advance pancreatic cancer patient need chemotherapeutic regimen able prevent much possible progression disease . Nab-paclitaxel ( Abraxane ) recently demonstrate interesting activity profile advance pancreatic cancer . A combination Nab-paclitaxel gemcitabine demonstrate superior gemcitabine alone metastatic patient .</brief_summary>
	<brief_title>Abraxane Gemcitabine Versus Gemcitabine Alone Locally Advanced Unresectable Pancreatic Cancer .</brief_title>
	<detailed_description>Study population : Locally advance unresectable pancreatic cancer patient Elegibility criterion : - Written inform consent - Age &gt; 18 &lt; 75 year - Histologically/cytologically confirm locally advanced , unresectable pancreatic cancer - At least one lesion measurable CT MRI scan - Performance Status ( ECOG ) 0-1 study entry - Life expectancy least 3 month - Adequate marrow , liver renal function - Effective contraception risk conception exists ( Informed Consent patient description possible contraceptive report</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Written inform consent Age &gt; 18 &lt; 75 year Histologically/cytologically confirm locally advance , unresectable pancreatic cancer At least one lesion measurable CT MRI scan Performance Status ( ECOG ) 01 study entry Life expectancy least 3 month Adequate marrow , liver renal function Effective contraception risk conception exists ( Informed Consent patient description possible contraceptive report ) Previous chemotherapy radiotherapy pancreatic cancer Severe cardiovascular disease Thrombotic embolic event Acute subacute intestinal occlusion history inflammatory bowel disease Known hypersensitivity study drug Known drug alcohol abuse Pregnant breastfeed woman Previous concurrent malignancy ; except basal squamous cell skin cancer and/or situ carcinoma cervix , solid tumor treat curatively evidence recurrence least 5 year prior randomization Unable sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>pancreatic cancer</keyword>
	<keyword>locally advanced</keyword>
	<keyword>unresectable cancer</keyword>
</DOC>